Hybrid (In person and virtual) meeting covering a broad range of topics including deep science and translational, clinical and commercial development in the field of CAR T. The programme will bring you all the latest in CAR T and will even bring in the first ever reported clinical data. Join the meeting to be able to hear the latest developments and to have the chance to discuss this important topic with both experts and your peers.
The target audience is hematologists, oncologists, physicians, nurses, data managers, supply chain managers and patient organization representatives.